Structural, functional and spectroscopic MRI studies of methamphetamine addiction

Current Topics in Behavioral Neurosciences

Volumn 11, Issue , 2011, Pages 321-364

  Salo, Ruth ^a   Fassbender, Catherine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Addiction; Amphetamine; Functional; Imaging; Methamphetamine; Structural

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE;

ANISOTROPY; ARTICLE; COGNITION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DRUG ABUSE; DRUG ABUSE PATTERN; EMOTION; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; METHAMPHETAMINE DEPENDENCE; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REWARD; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER; BRAIN; DIAGNOSIS; DIAGNOSTIC IMAGING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SCINTISCANNING;

AMPHETAMINE-RELATED DISORDERS; BRAIN; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; METHAMPHETAMINE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84867987937     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_172     Document Type: Article

References (132)

1. Aboitiz F, Rodriguez E, Olivares R, Zaidel E (1996) Age-related changes in fibre composition of the human corpus callosum: sex differences. Neuroreport 7: 1761-1764
2. Alicata D, Chang L, Cloak C, Abe K, Ernst T (2009) Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res 174: 1-8
3. Axt KJ, Molliver ME (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9: 302-313
4. Bae SC, Lyoo IK, Sung YH, Yoo J, Chung A, Yoon SJ, Kim DJ, Hwang J, Kim SJ, Renshaw PF (2006) Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Depend 81: 83-88
5. Barkovich AJ, Miller SP, Bartha A, Newton N, Hamrick SE, Mukherjee P, Glenn OA, Xu D, Partridge JC, Ferriero DM, Vigneron DB (2006) MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 27: 533-547
6. Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P (2000) Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res 98: 93-102
7. Berman S, O'Neill J, Fears S, Bartzokis G, London ED (2008) Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 1141: 195-220
8. Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ (2008) Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? J Neurosci 28: 9850-9856
9. Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ (2010) Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse 64: 417-420
10. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T (2005) Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 57: 967-974
11. Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(1): 16-32
12. Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH, Sim ME, Song IC, Kim J, Chang KH, Renshaw PF (2007) Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 10: 765-775
13. Compton WM, Thomas YF, Conway KP, Colliver JD (2005) Developments in the epidemiology of drug use and drug use disorders. Am J Psychiatry 162: 1494-1502
14. Damasio AR (1996) The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351: 1413-1420
15. Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 36: 1-22
16. de la Fuente-Fernandez R, Sossi V, McCormick S, Schulzer M, Ruth TJ, Stoessl AJ (2009) Visualizing vesicular dopamine dynamics in Parkinson's disease. Synapse 63: 713-716
17. Derogatis LR, Melisaratos N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13: 595-605
18. Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull 9: 13-28
19. Ernst T, Chang L (2008) Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 3: 165-172
20. Ernst T, Chang L, Leonido-Yee M, Speck O (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54: 1344-1349
21. Escubedo E, Guitart L, Sureda FX, Jimenez A, Pubill D, Pallas M, Camins A, Camarasa J (1998) Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats. Brain Res 814: 120-126
22. Fowler JS, Volkow ND, Logan J, Alexoff D, Telang F, Wang GJ, Wong C, Ma Y, Kriplani A, Pradhan K, Schlyer D, Jayne M, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog K (2008) Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. Neuroimage 43: 756-763
23. Frey K, Kilbourn M, Robinson T (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 334: 273-279
24. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612
25. Grachev ID, Kumar R, Ramachandran TS, Szeverenyi NM (2001) Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo (1)H-MRS study of the Stroop Color-Word task. Mol Psychiatry 6(496): 529-439
26. Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M (1987) The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab 7: 173-177
27. Hoffman WF, Schwartz DL, Huckans MS, McFarland BH, Meiri G, Stevens AA, Mitchell SH (2008) Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) 201: 183-193
28. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ (2004) Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 51: 435-440
29. Iyo M, Nishio M, Itoh T, Fukuda H, Suzuki K, Yamasaki T, Fukui S, Tateno Y (1993) Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography. Psychiatry Res 50: 217-231
30. Iyo M, Sekine Y, Mori N (2004) Neuromechanism of developing methamphetamine psychosis: a neuroimaging study. Ann N Y Acad Sci 1025: 288-295
31. Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR (2006) Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl) 185: 327-338
32. Jung RE, Yeo RA, Chiulli SJ, Sibbitt WL Jr, Weers DC, Hart BL, Brooks WM (1999) Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. Neuroreport 10: 3327-3331
33. Kerns JG, Cohen JD, MacDonald AW 3rd, Cho RY, Stenger VA, Carter CS (2004) Anterior cingulate conflict monitoring and adjustments in control. Science 303: 1023-1026
34. Kim SJ, Lyoo IK, Hwang J, Chung A, Hoon Sung Y, Kim J, Kwon DH, Chang KH, Renshaw PF (2006) Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol 9: 221-228
35. Kim IS, Kim YT, Song HJ, Lee JJ, Kwon DH, Lee HJ, Kim MN, Yoo DS, Chang Y (2009a) Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts. Neurotoxicology 30: 209-213
36. Kim YT, Lee SW, Kwon DH, Seo JH, Ahn BC, Lee J (2009b) Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers. J Psychiatry Res 43: 1166-1170
37. Kim YT, Kwon DH, Chang Y (2011) Impairments of facial emotion recognition and theory of mind in methamphetamine abusers. Psychiatry Res 186: 80-84
38. Kita T, Wagner GC, Nakashima T (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92: 178-195
39. Kubicki M, Westin CF, Maier SE, Mamata H, Frumin M, Ersner-Hershfield H, Kikinis R, Jolesz FA, McCarley R, Shenton ME (2002) Diffusion tensor imaging and its application to neuropsychiatric disorders. Harv Rev Psychiatry 10: 324-336
40. Kubicki M, Westin CF, McCarley RW, Shenton ME (2005) The application of DTI to investigate white matter abnormalities in schizophrenia. Ann N Y Acad Sci 1064: 134-148
41. LaMantia AS, Rakic P (1990) Axon overproduction and elimination in the corpus callosum of the developing rhesus monkey. J Neurosci 10: 2156-2175
42. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 47: 493-503
43. Leland DS, Arce E, Miller DA, Paulus MP (2008) Anterior cingulate cortex and benefit of predictive cueing on response inhibition in stimulant dependent individuals. Biol Psychiatry 63: 184-190
44. Lim KO, Helpern JA (2002) Neuropsychiatric applications of DTI-a review. NMR Biomed 15: 587-593
45. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002) Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51: 890-895
46. Lim KO, Wozniak JR, Mueller BA, Franc DT, Specker SM, Rodriguez CP, Silverman AB, Rotrosen JP (2008) Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend 92: 164-172
47. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61: 73-84
48. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W (2005) Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 58: 770-778
49. Madden DJ, Whiting WL, Huettel SA, White LE, MacFall JR, Provenzale JM (2004) Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time. Neuroimage 21: 1174-1181
50. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35, 428. J Neurosci 18: 8417-8422
51. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA (2008) Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62: 91-100
52. McClure SM, Laibson DI, Loewenstein G, Cohen JD (2004a) Separate neural systems value immediate and delayed monetary rewards. Science 306: 503-507
53. McClure SM, York MK, Montague PR (2004b) The neural substrates of reward processing in humans: the modern role of FMRI. Neuroscientist 10: 260-268
54. McClure SM et al (2007) Time discounting for primary rewards. J Neurosci 27: 5796-5804
55. Melega WP, Quintana J, Raleigh MJ, Stout DB, Yu DC, Lin KP, Huang SC, Phelps ME (1996) 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 22: 63-69
56. Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, Valdes I, Swann AC, Barratt ES, Narayana PA (2005) Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 30: 610-617
57. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89-131
58. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600: 649-661, discussion 661-644
59. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED (2007) Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp 28: 383-393
60. Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ (2004) Why is parkinsonism not a feature of human methamphetamine users? Brain 127: 363-370
61. Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M, Galloway GP, Pfefferbaum A, Spielman DM, Adalsteinsson E, Sullivan EV (2002) Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 116: 43-52
62. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH (2005) Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 62: 444-452
63. Oh JS, Lyoo IK, Sung YH, Hwang J, Kim J, Chung A, Park KS, Kim SJ, Renshaw PF, Song IC (2005) Shape changes of the corpus callosum in abstinent methamphetamine users. Neurosci Lett 384: 76-81
64. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8: 2788-2803
65. Ohmori T, Abekawa T, Koyama T (1996) The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 29: 301-307
66. Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges US, Fiebich M, Arolt V, Heindel W, Pfleiderer B (2004) Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 15: 549-553
67. Olausson P, Jentsch JD, Krueger DD, Tronson NC, Nairn AC, Taylor JR (2007) Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate. Ann N Y Acad Sci 1121: 610-638
68. O'Sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS (2001) Evidence for cortical ''disconnection'' as a mechanismof age-related cognitive decline. Neurology 57: 632-638
69. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychological Rep 10: 799-812
70. Pandya DN, Seltzer B (1986) The topography of commissural fibers. In: Lepore F, Ptito M, Jasper HH (eds) Two hemispheres-one brain: functions of the corpus callosum. Alan R. Liss, Inc., New York, pp 47-74
71. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA (2002) Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26: 53-63
72. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA (2003) Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 53: 65-74
73. Paulus MP, Tapert SF, Schuckit MA (2005) Neural activation patterns of methamphetaminedependent subjects during decision making predict relapse. Arch Gen Psychiatry 62: 761-768
74. Paulus MP, Lovero KL, Wittmann M, Leland DS (2008) Reduced behavioral and neural activation in stimulant users to different error rates during decision making. Biol Psychiatry 63: 1054-1060
75. Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED (2008) Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug Alcohol Depend 93: 93-102
76. Payer DE, Lieberman MD, London ED (2011) Neural correlates of affect Processing and aggression in methamphetamine dependence. Arch Gen Psychiatry 68: 271-282
77. Pfefferbaum A, Sullivan EV (2005) Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology 30: 423-432
78. Pfefferbaum A, Sullivan EV, Hedehus M, Adalsteinsson E, Lim KO, Moseley M (2000) In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res 24: 1214-1221
79. Pfefferbaum A, Adalsteinsson E, Sullivan EV (2005) Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 26: 891-899
80. PfefferbaumA, Adalsteinsson E, SullivanEV(2006)Dysmorphology and microstructural degradation of the corpus callosum: Interaction of age and alcoholism. Neurobiol Aging 27: 994-1009
81. Preston KL, Wagner GC, Schuster CR, Seiden LS (1985) Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res 338: 243-248
82. Quinton MS, Yamamoto BK (2006) Causes and consequences of methamphetamine and MDMA toxicity. Aaps J 8: E337-E347
83. Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193: 153-163
84. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235: 93-103
85. Ricaurte GA, Seiden LS, Schuster CR (1984) Further evidence that amphetamines produce longlasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303: 359-364
86. Ricaurte GA, Sabol KE, Seiden LS (1994) Functional consequences of neurotoxic amphetamine exposure. In: Cho AK, Segal DS (eds) Amphetamine and its analogs. Academic Press, San Diego, pp 297-313
87. Rockland KS, Pandya DN (1986) Topography of occipital lobe commissural connections in the rhesus monkey. Brain Res 365: 174-178
88. Sailasuta N, Abulseoud O, Harris KC, Ross BD (2010a) Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 30: 950-960
89. Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD (2010b) Metabolic abnormalities in abstinent methamphetamine dependent subjects. Subst Abuse 2010: 9-20
90. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, BuonocoreMH (2007) Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61: 1272-1280
91. Salo R, Nordahl TE, Buonocore MH, Natsuaki Y, Waters C, Moore CD, Galloway GP, LeamonMH (2009a) Cognitive control and white matter callosal microstructure in methamphetaminedependent subjects: a diffusion tensor imaging study. Biol Psychiatry 65: 122-128
92. Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, LeamonMH(2009b) Drug abstinence and cognitive control in methamphetamine-dependent individuals. J Subst Abuse Treat 37: 292-297
93. Salo R, Ursu S, Buonocore MH, Leamon MH, Carter C (2009c) Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol Psychiatry 65: 706-709
94. Salo R, Buonocore MH, Leamon M, Natsuaki Y, Waters C, Moore CD, Galloway GP, Nordahl TE (2011a) Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study. Drug Alcohol Depend 113: 133-138
95. Salo R, Nordahl TE, Buonocore MH, Natsuaki YT, Moore CD, Waters C, Leamon MH (2011b) Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging study. Neuropsychologia 49: 830-838
96. Schulte T, Sullivan EV, Muller-Oehring EM, Adalsteinsson E, Pfefferbaum A (2005) Corpus callosal microstructural integrity influences interhemispheric processing: a diffusion tensor imaging study. Cereb Cortex 15: 1384-1392
97. Schwartz DL, Mitchell AD, Lahna DL, Luber HS, Huckans MS, Mitchell SH, Hoffman WF (2010) Global and local morphometric differences in recently abstinent methamphetaminedependent individuals. Neuroimage 50: 1392-1401
98. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158: 1206-1214
99. Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara H, Ashby CR Jr, Takei N, Mori N (2002) Metabolite alterations in basal ganglia associated with methamphetaminerelated psychiatric symptoms. A proton MRS study. Neuropsychopharmacology 27: 453-461
100. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N (2003) Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160: 1699-1701
101. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63: 90-100
102. Sellitto M, Ciaramelli E, di Pellegrino G (2010) Myopic discounting of future rewards after medial orbitofrontal damage in humans. J Neurosci 30: 16429-16436
103. Sheng P, Cerruti C, Cadet JL (1994) Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide. Life Sci 55: PL51-PL54
104. Simon SL, Dean AC, Cordova X, Monterosso JR, London ED (2010) Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs 71: 335-344
105. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436
106. Sonsalla PK, Gibb JW, Hanson GR (1986) Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 238: 932-937
107. Sossi V, Holden JE, Topping GJ, Camborde ML, Kornelsen RA, McCormick SE, Greene J, Studenov AR, Ruth TJ, Doudet DJ (2007) In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD. J Cereb Blood Flow Metab 27: 1407-1415
108. Strome EM, Cepeda IL, Sossi V, Doudet DJ (2006) Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. Mol Imaging Biol 8: 292-299
109. Sullivan EV, Pfefferbaum A (2003) Diffusion tensor imaging in normal aging and neuropsychiatric disorders. Eur J Radiol 45: 244-255
110. Sullivan EV, Adalsteinsson E, Hedehus M, Ju C, Moseley M, Lim KO, Pfefferbaum A (2001) Equivalent disruption of regional white matter microstructure in ageing healthy men and women. Neuroreport 12: 99-104
111. Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK (2007) Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug Alcohol Depend 88: 28-35
112. Tata DA, Yamamoto BK (2007) Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction 102(1): 49-60
113. Taylor MJ, Alhassoon OM, Schweinsburg BC, Videen JS, Grant I (2000) MR spectroscopy in HIV and stimulant dependence HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 6: 83-85
114. Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I (2007) Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol 13: 150-159
115. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24: 6028-6036
116. Tobias MC, O'Neill J, Hudkins M, Bartzokis G, Dean AC, London ED (2010) White-matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacology (Berl) 209: 13-24
117. Tsai G, Coyle JT (1995) N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46: 531-540
118. Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294: 577-583
119. Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA (1998) Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35, 428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18: 419-427
120. Volkow ND (2005) What do we know about drug addiction? Am J Psychiatry 162: 1401-1402
121. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001a) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021
122. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J (2001b) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418
123. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J (2001c) Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 158: 383-389
124. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001d) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377-382
125. Volkow ND, Fowler JS, Wang GJ, Shumay E, Telang F, Thanos PK, Alexoff D (2010) Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS One 5: e15269
126. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS (1980a) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30: 547-550
127. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980b) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151-160
128. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS (2004) Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161: 242-248
129. Wechsler D (1981) Manual for the Wechsler adult intelligence scale-revised. Psychological Corporation, New York
130. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699-703
131. Yamamoto BK, Bankson MG (2005) Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol 17: 87-117
132. Zhou FC, Bledsoe S (1996) Methamphetamine causes rapid varicosis, perforation and definitive degeneration of serotonin fibers: an immunocytochemical study of serotnin trasnporter. In: Neuroscience-Net, pp 1-17